Wegovy and Constant Burping: What's Going On and When It Matters

Burping on Wegovy is driven by slowed gastric emptying, a core mechanism of semaglutide that also underpins its appetite-reducing effect.
It most often peaks in the first few weeks of treatment or shortly after a dose increase, then eases as the body adjusts.
Dietary changes, eating pace and meal size all influence how much gas builds up, giving you practical levers to pull.
Persistent, severe or worsening upper abdominal symptoms should always be discussed with your prescriber, not managed alone.

Persistent burping is one of the more unexpected complaints people raise after starting Wegovy. Semaglutide slows how quickly food leaves the stomach, and that delay in gastric emptying is the direct reason so many people find themselves burping far more than usual, sometimes for hours after eating. It is unsettling but, for most people, it is not a sign that something has gone seriously wrong. These are prescription-only medicines that require clinical assessment, and a prescriber is best placed to judge whether what you're experiencing is within the expected range or needs a closer look.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

Understanding the Burping, Deciding What to Do About It

Why semaglutide causes this in the first place

Wegovy works partly by acting on receptors that govern the rate at which your stomach empties its contents into the small intestine. When that rate slows, food and gas sit in the stomach longer than they normally would. The result is pressure, fullness and, for many people, a lot of burping that is worth understanding in more detail. This is the same mechanism that reduces appetite, so the burping is not a malfunction; it is a side effect of something the medicine is deliberately doing.

The NHS semaglutide medicines page lists burping (eructation) among the common gastrointestinal effects of semaglutide, alongside nausea, reflux and bloating. Most people find these effects are worst around the first two to four weeks of a new dose. After a dose increase the cycle can repeat, which is why someone who had settled down at 1mg might find themselves burping constantly again after moving to 1.7mg. That pattern, uncomfortable as it is, tends to resolve with time.

If you want a broader map of how semaglutide's GI effects fit together, the full Wegovy side effects guide covers the whole picture in one place.

The decision that matters: is your burping typical or a warning sign?

Most burping on Wegovy is a nuisance, not a danger. But it is worth knowing the difference. Typical burping is frequent, often sulfurous (that egg-like quality is common), usually connected to eating and tends to ease between meals. It does not come with severe pain and it does not stop you functioning.

The picture that needs urgent attention is different. If the burping is accompanied by severe, persistent upper abdominal or stomach pain that spreads toward the back, that combination should prompt you to seek medical help without delay, because it can be a symptom of acute pancreatitis. In January 2026 the MHRA issued a Drug Safety Update specifically highlighting acute pancreatitis as an infrequent but serious risk with GLP-1 medicines, and the hallmark symptom is exactly that kind of radiating abdominal pain. It is uncommon; knowing about it means you would act quickly if it happened.

Persistent nausea alongside the burping, or symptoms that are getting worse rather than plateauing after a few weeks, also warrant a conversation with your prescriber. You can explore what to expect in the early days of Wegovy if you are unsure whether what you are experiencing falls within the normal early window.

Practical things that genuinely help

Because the underlying cause is gas held in a slower-moving stomach, a few changes to how you eat can make a real difference to the frequency and intensity of burping. None of these are cures, but people on semaglutide often find them worth trying.

Eating slowly and chewing thoroughly reduces the amount of air swallowed with each bite. Smaller, more frequent meals put less total volume in the stomach at once, giving that slowed emptying less to contend with. Carbonated drinks are worth avoiding or at least reducing, since fizz adds gas directly. Fatty and heavily processed foods tend to sit in the stomach longer even without semaglutide in the picture; on Wegovy their effect is amplified. Some people also find that sitting upright for thirty to forty-five minutes after eating helps noticeably.

A practical note: if you are taking Wegovy in the morning, many people build the injection into a routine already anchored to the fridge, such as before breakfast when they are getting other things out anyway. Keeping that consistency with meal timing and size tends to make the GI pattern more predictable and easier to manage. More on managing day-to-day symptoms is in the semaglutide burping guide.

If diarrhoea is also part of what you are dealing with, the guide to diarrhoea on Wegovy covers that separately, since the management approach differs.

When to talk to a prescriber and what they can actually do

A prescriber reviewing your experience has several options. Sometimes the advice is simply to wait, with reassurance that what you are describing is a recognised pattern and within the expected range. In other cases, they might suggest a slower titration, staying at the current dose for longer before increasing, which gives the GI system more time to adapt. If symptoms are severe enough to affect eating and nutrition, that changes the risk-benefit calculation and they will want to weigh that carefully.

At nume, your prescribers are real clinicians reviewing every case personally, and that review happens before every repeat as well. If burping or any other symptom is making treatment difficult, that is exactly the kind of thing to raise. You can also read more about whether burping is a recognised Wegovy side effect for a more detailed clinical breakdown. And if you have not yet started treatment and are wondering whether Wegovy is right for your situation, our free consultation is the right starting point. A prescriber will look at your full picture, not just a symptom list.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions